Skip to main content
Top

Management of obesity in an individual with ROHHAD syndrome with semaglutide 2.4 mg/week: a case report

Published in:

Excerpt

Dear Editor, …
Title
Management of obesity in an individual with ROHHAD syndrome with semaglutide 2.4 mg/week: a case report
Authors
Jean-baptiste Bonnet
Clotilde Ramillon-Cury
Sarah Tournayre
Ariane Sultan
Antoine Avignon
Publication date
28-09-2024
Publisher
Springer Berlin Heidelberg
Published in
Clinical Autonomic Research / Issue 1/2025
Print ISSN: 0959-9851
Electronic ISSN: 1619-1560
DOI
https://doi.org/10.1007/s10286-024-01072-x
This content is only visible if you are logged in and have the appropriate permissions.

Keynote webinar | Spotlight on functional neurological disorder

FND perplexes and frustrates patients and physicians alike. Limited knowledge and insufficient awareness delays diagnosis and treatment, and many patients feel misunderstood and stigmatized. How can you recognize FND and what are the treatment options?

Prof. Mark Edwards
Watch now
Video

How can you integrate PET into your practice? (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)™

PET imaging is playing an increasingly critical role in managing AD. Our expert-led program will empower you with practical strategies and real-world case studies to effectively integrate it into clinical practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Learn more
Image Credits
Human brain illustration/© (M) CHRISTOPH BURGSTEDT / SCIENCE PHOTO LIBRARY / Getty Images, Navigating neuroimaging in Alzheimer’s care: Practical applications and strategies for integration/© Springer Health+ IME